Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Xeris Biopharma Holdings Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Xeris Biopharma Holdings Inc. June 4, 202671.5%
-
Xeris Biopharma Holdings Inc. June 7, 202392.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2026 | Xeris Biopharma Holdings Inc. | Open-market sale | −20,000 | $6.09 | $121,800 |
| Jun 4, 2026 | Xeris Biopharma Holdings Inc. | Grant or award | +24,193 | — | — |
| Aug 12, 2025 | Xeris Biopharma Holdings Inc. | Open-market sale | −42,500 | $7.28 | $309,400 |
| Jun 4, 2025 | Xeris Biopharma Holdings Inc. | Grant or award | +50,000 | — | — |
| Jun 5, 2024 | Xeris Biopharma Holdings Inc. | Grant or award | +50,000 | — | — |
| Nov 20, 2023 | Xeris Biopharma Holdings Inc. | Open-market purchase | +5,410 | $1.84 | $9,954 |
| Jun 7, 2023 | Xeris Biopharma Holdings Inc. | Grant or award | +42,500 | — | — |
Questions about Dawn Halkuff
What boards is Dawn Halkuff on?
Dawn Halkuff sits on the board of Xeris Biopharma Holdings Inc.
How long has Dawn Halkuff served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.